全文获取类型
收费全文 | 4788篇 |
免费 | 437篇 |
国内免费 | 6篇 |
出版年
2023年 | 28篇 |
2022年 | 56篇 |
2021年 | 124篇 |
2020年 | 76篇 |
2019年 | 80篇 |
2018年 | 102篇 |
2017年 | 84篇 |
2016年 | 155篇 |
2015年 | 241篇 |
2014年 | 259篇 |
2013年 | 294篇 |
2012年 | 354篇 |
2011年 | 347篇 |
2010年 | 254篇 |
2009年 | 194篇 |
2008年 | 248篇 |
2007年 | 227篇 |
2006年 | 235篇 |
2005年 | 226篇 |
2004年 | 202篇 |
2003年 | 189篇 |
2002年 | 174篇 |
2001年 | 82篇 |
2000年 | 49篇 |
1999年 | 43篇 |
1998年 | 43篇 |
1997年 | 36篇 |
1996年 | 38篇 |
1995年 | 39篇 |
1994年 | 34篇 |
1993年 | 28篇 |
1992年 | 32篇 |
1991年 | 34篇 |
1990年 | 30篇 |
1989年 | 35篇 |
1988年 | 22篇 |
1987年 | 23篇 |
1986年 | 25篇 |
1985年 | 32篇 |
1984年 | 33篇 |
1983年 | 35篇 |
1982年 | 25篇 |
1979年 | 22篇 |
1978年 | 21篇 |
1977年 | 27篇 |
1976年 | 21篇 |
1975年 | 20篇 |
1974年 | 22篇 |
1972年 | 18篇 |
1970年 | 21篇 |
排序方式: 共有5231条查询结果,搜索用时 15 毫秒
1.
2.
Anthony J. Hesketh Caroline Maloney Christopher A. Behr Morris C. Edelman Richard D. Glick Yousef Al-Abed Marc Symons Samuel Z. Soffer Bettie M. Steinberg 《PloS one》2015,10(12)
Metastatic Ewing Sarcoma carries a poor prognosis, and novel therapeutics to prevent and treat metastatic disease are greatly needed. Recent evidence demonstrates that tumor-associated macrophages in Ewing Sarcoma are associated with more advanced disease. While some macrophage phenotypes (M1) exhibit anti-tumor activity, distinct phenotypes (M2) may contribute to malignant progression and metastasis. In this study, we show that M2 macrophages promote Ewing Sarcoma invasion and extravasation, pointing to a potential target of anti-metastatic therapy. CNI-1493 is a selective inhibitor of macrophage function and has shown to be safe in clinical trials as an anti-inflammatory agent. In a xenograft mouse model of metastatic Ewing Sarcoma, CNI-1493 treatment dramatically reduces metastatic tumor burden. Furthermore, metastases in treated animals have a less invasive morphology. We show in vitro that CNI-1493 decreases M2-stimulated Ewing Sarcoma tumor cell invasion and extravasation, offering a functional mechanism through which CNI-1493 attenuates metastasis. These data indicate that CNI-1493 may be a safe and effective adjuvant agent for the prevention and treatment of metastatic Ewing Sarcoma. 相似文献
3.
4.
Nina Boiko Volodymyr Kucher Benjamin A. Eaton James D. Stockand 《The Journal of biological chemistry》2013,288(13):9418-9427
The voltage-gated K+ (Kv) channel blocker 4-aminopyridine (4-AP) is used to target symptoms of the neuroinflammatory disease multiple sclerosis (MS). By blocking Kv channels, 4-AP facilitates action potential conduction and neurotransmitter release in presynaptic neurons, lessening the effects of demyelination. Because they conduct inward Na+ and Ca2+ currents that contribute to axonal degeneration in response to inflammatory conditions, acid-sensing ion channels (ASICs) contribute to the pathology of MS. Consequently, ASICs are emerging as disease-modifying targets in MS. Surprisingly, as first demonstrated here, 4-AP inhibits neuronal degenerin/epithelial Na+ (Deg/ENaC) channels, including ASIC and BLINaC. This effect is specific for 4-AP compared with its heterocyclic base, pyridine, and the related derivative, 4-methylpyridine; and akin to the actions of 4-AP on the structurally unrelated Kv channels, dose- and voltage-dependent. 4-AP has differential actions on distinct ASICs, strongly inhibiting ASIC1a channels expressed in central neurons but being without effect on ASIC3, which is enriched in peripheral sensory neurons. The voltage dependence of the 4-AP block and the single binding site for this inhibitor are consistent with 4-AP binding in the pore of Deg/ENaC channels as it does Kv channels, suggesting a similar mechanism of inhibition in these two classes of channels. These findings argue that effects on both Kv and Deg/ENaC channels should be considered when evaluating the actions of 4-AP. Importantly, the current results are consistent with 4-AP influencing the symptoms of MS as well as the course of the disease because of inhibitory actions on Kv and ASIC channels, respectively. 相似文献
5.
Hetron Mweemba Munang’andu Nina Santi B?rge Nilsen Fredriksen Knut-Egil L?kling ?ystein Evensen 《PloS one》2016,11(2)
A cohabitation challenge model was developed for use in evaluating the efficacy of vaccines developed against infectious pancreatic necrosis virus (IPNV) in Atlantic salmon (Salmo salar L) using a stepwise approach. The study involved identifying a set of input variables that were optimized before inclusion in the model. Input variables identified included the highly virulent Norwegian Sp strain NVI015-TA encoding the T217A221 motif having the ability to cause >90% mortality and a hazard risk ratio of 490.18 (p<0.000) for use as challenge virus. The challenge dose was estimated at 1x107 TCID50/mL per fish while the proportion of virus shedders was estimated at 12.5% of the total number of fish per tank. The model was designed based on a three parallel tank system in which the Cox hazard proportional regression model was used to estimate the minimum number of fish required to show significant differences between the vaccinated and control fish in each tank. All input variables were optimized to generate mortality >75% in the unvaccinated fish in order to attain a high discriminatory capacity (DC) between the vaccinated and control fish as a measure of vaccine efficacy. The model shows the importance of using highly susceptible fish to IPNV in the optimization of challenge models by showing that highly susceptible fish had a better DC of differentiating vaccine protected fish from the unvaccinated control fish than the less susceptible fish. Once all input variables were optimized, the model was tested for its reproducibility by generating similar results from three independent cohabitation challenge trials using the same input variables. Overall, data presented here show that the cohabitation challenge model developed in this study is reproducible and that it can reliably be used to evaluate the efficacy of vaccines developed against IPNV in Atlantic salmon. We envision that the approach used here will open new avenues for developing optimal challenge models for use in evaluating the efficacy of different vaccines used in aquaculture. 相似文献
6.
7.
8.
S J Richman M Goodman T M Nguyen P W Schiller 《International journal of peptide and protein research》1985,25(6):648-662
As part of our continuing effort to define structure-activity relationships for enkephalin and design enzymatically resistant analogs, we report the synthesis and biological activities of linear and cyclic enkephalin analogs modified at the Gly3-Phe4 amide bond. The partial retro-inverso enkephalin analog Tyr-D-Ala-gGly-(R,S)-mPhe-Leu-NH2 and its cyclic counterpart, Tyr-cyclo[D-A2 bu-gGly-(R,S)-mPhe-Leu-], were synthesized as diastereomeric mixtures using solution methodology. The racemic benzylmalonate allowed the linear analog to be synthesized by fragment coupling at the reversed bond. Cyclization of the second analog was carried out at high concentration, eliminating formation of polymer by the use of an insoluble base. All gem-diaminoalkyl residues were prepared by conversion of peptidyl amides with benzene iodonium bis(trifluoroacetate). Diastereomers of both compounds were separable by reverse phase HPLC but those of the linear compound racemized rapidly under conditions of testing and were therefore tested together. All analogs tested had activities ranging from 6 to 14% of the activity of Leu enkephalin, indicating that the Gly3-Phe4 amide bond is important, though not crucial, for receptor binding. 相似文献
9.
Dr. Josef Schiller 《Plant Systematics and Evolution》1907,57(6):235-237
Ohne Zusammenfassung 相似文献
10.